News

Su equipo de atención puede recomendar terapias sistémicas para tratar el cáncer pulmonar. Es posible que reciba terapia neoadyuvante, que es el tratamiento que se administra antes de la cirugía para ...
When you join MSK Healthy Living, our experts will create a personal lifestyle plan for you. First, you will fill out a questionnaire that asks you questions about your goals and needs. The survey is ...
A New Way to Help In March 2018, MSK established the first center in the world devoted to the specific needs of colorectal cancer patients under 50. TThe Center for Young Onset Colorectal Cancer was ...
What type of lung cancer do I have, and what stage is it? Did I have all the scans I need to learn the stage? What genetic testing do you offer for lung cancer? What are the best treatment options for ...
Memorial Sloan Kettering Cancer Center (MSK) and Curadev Pharma, Inc., a biotechnology company developing novel immuno-oncology therapeutics, are expanding their collaboration through the MSK ...
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to ...
Full Title A Phase II Randomized Study Comparing Ibrutinib and Rituximab vs. Venetoclax and Rituximab in Previously Untreated Waldenström's Macroglobulinemia (WM) /Lymphoplasmacytic Lymphoma ...
I am currently a PhD student working in the labs of Dr. Daniel Heller and Dr. Raphael Lis. Here I am using organoid models to further our understanding of heterogeneity across brain vasculature, and ...
Ready to start planning your care? Call us at 800-525-2225 to make an appointment ...
Children & Teens: 833-MSK-KIDS Monday through Friday, 9 a.m. to 5:30 p.m. (Eastern time) ...
Discover the joys of crafting your very own DIY terrarium and transform your space into a green oasis! Whether this is your first time or you are a crafty botanical enthusiasts, this virtual workshop ...
Dr. Michael Foote treats gastrointestinal cancers at MSK, including colorectal, pancreatic and rare appendiceal cancers, using personalized, targeted therapies.